• Consensus Rating: Moderate Buy
  • Consensus Price Target: $39.00
  • Forecasted Upside: 37.37%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$28.39
▼ -0.03 (-0.11%)

This chart shows the closing price for CHX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New ChampionX Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CHX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CHX

Analyst Price Target is $39.00
▲ +37.37% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for ChampionX in the last 3 months. The average price target is $39.00, with a high forecast of $51.00 and a low forecast of $32.00. The average price target represents a 37.37% upside from the last price of $28.39.

This chart shows the closing price for CHX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 4 contributing investment analysts is to moderate buy stock in ChampionX. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/9/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/7/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/5/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/3/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/3/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
8/1/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/30/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/30/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/15/2024Piper SandlerLower TargetNeutral ➝ Neutral$40.00 ➝ $33.00
4/8/2024Piper SandlerBoost TargetNeutral ➝ Neutral$32.00 ➝ $40.00
4/4/2024BarclaysBoost TargetOverweight ➝ Overweight$39.00 ➝ $51.00
3/27/2024CitigroupBoost TargetBuy ➝ Buy$39.00 ➝ $40.00
1/8/2024Piper SandlerDowngradeOverweight ➝ Neutral$38.00 ➝ $32.00
11/14/2023The Goldman Sachs GroupLower TargetNeutral ➝ Neutral$37.00 ➝ $32.00
10/27/2023Piper SandlerLower TargetOverweight ➝ Overweight$42.00 ➝ $38.00
10/26/2023Stifel NicolausLower TargetBuy ➝ Buy$41.00 ➝ $39.00
10/17/2023BarclaysUpgradeEqual Weight ➝ Overweight$33.00 ➝ $42.00
7/26/2023Piper SandlerBoost Target$36.00 ➝ $42.00
7/26/2023BarclaysBoost Target$32.00 ➝ $33.00
7/14/2023Capital One FinancialInitiated CoverageOverweight$40.00
4/5/2023CitigroupLower TargetBuy$41.00 ➝ $40.00
11/2/2022The Goldman Sachs GroupBoost TargetNeutral$21.00 ➝ $32.00
11/1/2022CitigroupBoost TargetBuy$30.00 ➝ $34.00
10/6/2022BarclaysDowngradeOverweight ➝ Equal Weight$38.00 ➝ $28.00
8/24/2022BenchmarkInitiated CoverageBuy$32.00
7/15/2022Bank of AmericaUpgradeNeutral ➝ Buy$25.00 ➝ $22.00
7/13/2022The Goldman Sachs GroupLower TargetNeutral$26.00 ➝ $21.00
5/2/2022BarclaysBoost Target$33.00 ➝ $38.00
4/11/2022Piper SandlerUpgradeNeutral ➝ Overweight$28.00 ➝ $30.00
3/11/2022Bank of AmericaDowngradeBuy ➝ Neutral
2/22/2022The Goldman Sachs GroupUpgradeSell ➝ Neutral$24.00
11/1/2021BarclaysBoost TargetOverweight$29.00 ➝ $35.00
9/17/2021The Goldman Sachs GroupInitiated CoverageSell$22.00
8/30/2021COKER & PALMERUpgradeSector Underperform ➝ Sector Perform
7/8/2021Evercore ISIReiterated RatingBuy$25.00
7/2/2021Stifel NicolausBoost TargetBuy$26.00 ➝ $30.00
3/3/2021Piper SandlerBoost TargetNeutral$12.25 ➝ $18.00
2/26/2021BarclaysBoost TargetOverweight$23.00 ➝ $29.00
2/25/2021Credit Suisse GroupBoost TargetOutperform$18.50 ➝ $21.50
2/25/2021Wells Fargo & CompanyBoost TargetOverweight$19.00 ➝ $24.00
2/25/2021CowenBoost TargetOutperform$22.00 ➝ $26.00
1/11/2021BarclaysReiterated RatingOverweight
12/21/2020The Goldman Sachs GroupInitiated CoverageBuy$21.00
12/15/2020Smith Barney CitigroupBoost Target$15.00 ➝ $18.00
11/2/2020BarclaysBoost TargetOverweight$16.00 ➝ $19.00
10/30/2020Credit Suisse GroupBoost TargetOutperform$13.00 ➝ $15.00
10/30/2020CowenBoost TargetOutperform$13.00 ➝ $18.00
10/7/2020Piper SandlerLower TargetNeutral$12.60 ➝ $11.60
9/15/2020ScotiabankInitiated CoverageSector Outperform$12.00
9/11/2020Credit Suisse GroupInitiated CoverageOutperform$13.00 ➝ $13.00
9/8/2020Evercore ISIUpgradeIn-Line ➝ Outperform$16.00
8/10/2020Piper SandlerBoost TargetNeutral$10.50 ➝ $12.60
6/25/2020Stifel NicolausInitiated CoverageBuy$15.00
6/22/2020Bank of AmericaInitiated CoverageBuy$12.00
(Data available from 10/30/2019 forward)

News Sentiment Rating

1.16 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 16 very positive mentions
  • 17 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/3/2024
  • 11 very positive mentions
  • 17 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/3/2024
  • 11 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/2/2024
  • 14 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/2/2024
  • 11 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/1/2024
  • 14 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/31/2024
  • 23 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/30/2024
  • 16 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
10/30/2024

Current Sentiment

  • 16 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Positive

ChampionX logo
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies. The Production Chemical Technologies segment offers onshore, offshore, and oil sands chemical solutions, such as corrosion inhibitors, scale inhibitors, emulsion breakers, and biocides to oil and natural gas production and midstream markets to manage and control corrosion, oil and water separation, flow assurance, sour gas treatment, and water-related issues. The Production & Automation Technologies segment provides artificial lift equipment, end-to-end digital automation solutions, and other production equipment and emissions monitoring solutions, including electrical submersible pumping systems, gas lift systems, jet pumps, multiplex surface pumps, plunger lift equipment, progressive cavity pumping systems, downhole rod lift systems, methane emissions monitoring solutions, chemical injection systems, flow control valves, and gauges under the Harbison-Fischer, Norris, Alberta Oil Tool, Oil Lift Technology, PCS Ferguson, Pro-Rod, Upco, Unbridled ESP, Norriseal-Wellmark, Quartzdyne, Spirit, Theta, Timberline, and Windrock brands. The Drilling Technologies segment offers polycrystalline diamond cutter inserts, bearings, valves, nozzles, and mining tools used in oil and gas drill bits under the US Synthetic brand; and high-density ceramic roof bolt mining tools for underground mining operations. The Reservoir Chemical Technologies segment provides chemistry-oriented solutions and technologies for well drilling, cementing, fracturing, acidizing, and other well interventions, as well as fracturing, drilling, cementing, acidizing additives. The company was founded in 1882 and is headquartered in The Woodlands, Texas.
Read More

Today's Range

Now: $28.39
Low: $28.26
High: $28.79

50 Day Range

MA: $30.42
Low: $28.19
High: $32.51

52 Week Range

Now: $28.39
Low: $25.46
High: $39.95

Volume

657,062 shs

Average Volume

1,860,957 shs

Market Capitalization

$5.41 billion

P/E Ratio

17.42

Dividend Yield

1.30%

Beta

2.37

Frequently Asked Questions

What sell-side analysts currently cover shares of ChampionX?

The following Wall Street analysts have issued reports on ChampionX in the last year: Barclays PLC, Citigroup Inc., Piper Sandler, and The Goldman Sachs Group, Inc..
View the latest analyst ratings for CHX.

What is the current price target for ChampionX?

4 Wall Street analysts have set twelve-month price targets for ChampionX in the last year. Their average twelve-month price target is $39.00, suggesting a possible upside of 36.4%. Barclays PLC has the highest price target set, predicting CHX will reach $51.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $32.00 for ChampionX in the next year.
View the latest price targets for CHX.

What is the current consensus analyst rating for ChampionX?

ChampionX currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for CHX.

What other companies compete with ChampionX?

How do I contact ChampionX's investor relations team?

ChampionX's physical mailing address is 2445 TECHNOLOGY FOREST BLVD BUILDING 4 FLOOR 12, THE WOODLANDS TX, 77381. The company's listed phone number is (281) 403-5772 and its investor relations email address is [email protected]. The official website for ChampionX is www.championx.com. Learn More about contacing ChampionX investor relations.